HOME >> BIOLOGY >> NEWS
Picking prostanoids to provide protection

Atherosclerosis is an inflammation in the lining of the arteries. Biological chemicals in the body called pros-tanoids, which are made from the breakdown of arachidonic acid by the action of an enzyme called COX have been implicated in the development of atherosclerosis. The role of prostanoids in inflammation is well known, based on studies of aspirin-like non-steroidal anti-inflammatory drugs, which act to inhibit the action of COX. Two prostenoids called PG I2/prostacyclin (PGI2) and thromboxane A2 (TXA2), are ele-vated in individuals with atheroscle-rosis, but their roles in the initiation and development of atherosclerosis remain ill-defined. To investigate the role of each of these prostanoids in atherosclerosis, Shuh Narumiya and colleagues, of Kyoto University Faculty of Medicine, have bred an ath-erosclerotic mouse model (apoE/) with mice that were deficient in either the PGI receptor (IP) or the TXA receptor (TP).

These mice allowed the authors to examine the effect of loss of PGI or TXA action on atherosclerosis development. Relative to apoE/ mice, the apoE/IP/ mice had accelerated initiation and development of athero-sclerosis, while the apoE/TP/ mice had delayed development. apoE/IP/ mice also demonstrated other mark-ers of more severe disease, compared with apoE/ mice. apoE/TP/ mice presented with fewer markers of dis-ease. These data indicate that PGI2 protects against and TXA2 promotes atherosclerosis development. The use of TP antagonists and molecules with PG-like activity may therefore aid in atherosclerosis prevention. Furthermore these data fit well with previous work that indicated that low doses of aspirin, which inhibits TXA2 more than PGI2, has been used as anti-platelet therapy for the prevention of myocardial infarction and recurrence of strokes.


'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Sep-2004


Page: 1

Related biology news :

1. Study by Israeli scientists provides insight on DNA code
2. Adaptive changes in the genome may provide insight into the genetics of complex disease
3. Essential smell gene may provide key to new insect repellents
4. Clemson University spin-off uses corn to make plastics, provide cleaner air
5. Method to visualize gene activity may provide insight into normal development & genome function
6. Study by Tufts biologist provides window into progression of some degenerative diseases
7. New discovery could provide tool to detect whether a cancer will develop and spread
8. Protective mechanism exploited by tumors may provide new cancer treatment
9. Rolling Store provides model for overcoming barriers to healthy foods and better health outcomes
10. Fat cells could provide the key to a longer life
11. Damaged genes in aging human brain provide clues to cognitive decline

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... 28, 2019 , ... In the development of biosimilars, the broad definition of ... task. Despite this uncertainty, several manufacturers have been successful and numerous follow-on biologics are ... this webinar, learn how analytical similarity is achieved in biosimilars based on recently approved ...
(Date:3/29/2019)... ... March 29, 2019 , ... ... partnership to expand their broad tissue-based biomarker development capabilities, as well as ... terms of the agreement, the companies will offer a comprehensive set of ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected G-CON ... therapy facility. The new facility, which will anchor the VelocityTX innovation center in ... art manufacturing capabilities to support clinical cell therapy trials. GenCure is a subsidiary ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... Cirrascale Cloud Services ... has extended its managed services offering to include NVIDIA® DGX™ systems. The company ... of the NVIDIA DGX-Ready Data Center program to deliver a Zero DevOps offering ...
(Date:3/19/2019)... BASEL, Switzerland (PRWEB) , ... ... ... Center at Tel HaShomer, the largest hospital in Israel and the Middle ... cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership will enable ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... in Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma ... Center as the fifth institution in Oklahoma to receive this prestigious endorsement. ...
(Date:3/14/2019)... ... March 13, 2019 , ... Murrieta Genomics , the ... bring industry specific and broader business experience to bear as genomic sequencing startups build ... to the knowledge and expertise that our Advisory Board brings to the table. Many ...
Breaking Biology Technology:
Cached News: